![Joey Mason](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Joey Mason
Direktor/Vorstandsmitglied bei
Spark Therapeutics Ireland Ltd.
Profil
Dr. Joey Mason, MD, is a Venture Partner at Claret Capital Partners Ltd., a Vice Chairman at Merck Ventures BV, an Independent Director at Genesis Automation Ltd. and an Independent Director at Rathmichael Residents Association Ltd. He is on the Board of Directors at Axial Medical Printing Ltd., Merck Ventures BV, Eumom Marketing Ltd., Delta Management Partners III Ltd., Delta Nominees Def Iii Ltd., European Private Equity & Venture Capital Association, Lightship Medical Ltd., Loki Steer Ltd., Optigen Patents Ltd., Plexium, Inc., Spark Therapeutics Ireland Ltd., Travale Ltd., Travale Marketing Ltd., Genesis Automation Ltd. and Rathmichael Residents Association Ltd.
Dr. Mason was previously employed as an Independent Director by SpineGuard SA, an Investment Manager by Delta Partners Ltd., a Co-Founder by Eumedia Ltd., a Co-Founder by Eumom Ltd., a Director-Corporate Development by Biotrin Holdings Ltd., a Non-Executive Director by AccuNostics Ltd., an Investment Banker by Morgan Stanley UK Group, and an Investment Banker by Technomark Consulting Services Ltd. He also served on the board at DNA Script SAS, GlySure Ltd., Heartscape Technologies, Inc., Indi Molecular, Inc., Miracor Medical SA, Neuravi Ltd. and NeuroCure Ltd.
He received his doctorate degree from Trinity College Dublin.
Aktive Positionen von Joey Mason
| Unternehmen | Position | Beginn |
|---|---|---|
Spark Therapeutics Ireland Ltd.
 Spark Therapeutics Ireland Ltd. Pharmaceuticals: MajorHealth Technology Develops new gene medicines to treat autosomal dominant genetic diseases | Direktor/Vorstandsmitglied | 06.09.2011 |
Eumom Marketing Ltd. | Direktor/Vorstandsmitglied | 01.01.2000 |
Travale Ltd. | Direktor/Vorstandsmitglied | - |
Travale Marketing Ltd. | Direktor/Vorstandsmitglied | - |
Delta Management Partners III Ltd.
 Delta Management Partners III Ltd. Investment Banks/BrokersFinance Provides security broking and fund management services | Direktor/Vorstandsmitglied | - |
Lightship Medical Ltd. | Direktor/Vorstandsmitglied | - |
European Private Equity & Venture Capital Association | Direktor/Vorstandsmitglied | - |
Rathmichael Residents Association Ltd. | Direktor/Vorstandsmitglied | - |
Genesis Automation Ltd.
 Genesis Automation Ltd. Packaged SoftwareTechnology Services Develops enterprise resource planning based technology modules for hospitals | Direktor/Vorstandsmitglied | - |
| ░░░░░ ░░░░░░░░ ░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░ | - |
Ehemalige bekannte Positionen von Joey Mason
| Unternehmen | Position | Ende |
|---|---|---|
| ░░░░░░░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░ ░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░░░░░░░ ░░░ ░░░ ░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Ausbildung von Joey Mason
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
89
Beziehungen ersten Grades
32
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 32 |
|---|---|
Heartscape Technologies, Inc.
 Heartscape Technologies, Inc. Medical SpecialtiesHealth Technology Develops and markets cardiology devices | Health Technology |
Delta Partners Ltd.
 Delta Partners Ltd. Investment ManagersFinance Delta Partners invests in companies located in the United Kingdom and Ireland. The firm focuses on sectors such as technology & med-tech companies. It provides financing for seed & early stage capital requirements. | Finance |
Technomark Consulting Services Ltd. | |
Trinity College Dublin
 Trinity College Dublin Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
European Private Equity & Venture Capital Association | |
Miracor Medical SA
 Miracor Medical SA Medical SpecialtiesHealth Technology Manufactures and sells medical devices to treat heart diseases | Health Technology |
Spark Therapeutics Ireland Ltd.
Spark Therapeutics Ireland Ltd. Pharmaceuticals: MajorHealth Technology Develops new gene medicines to treat autosomal dominant genetic diseases | Health Technology |
GlySure Ltd.
 GlySure Ltd. Medical SpecialtiesHealth Technology Develops glucose monitoring devices | Health Technology |
NeuroCure Ltd.
 NeuroCure Ltd. BiotechnologyHealth Technology Manufactures drugs to cure psychiatric and central nervous system diseases | Health Technology |
Delta Management Partners III Ltd.
Delta Management Partners III Ltd. Investment Banks/BrokersFinance Provides security broking and fund management services | Finance |
SpineGuard SA
 SpineGuard SA Medical SpecialtiesHealth Technology Designs and manufactures medical devices | Health Technology |
Morgan Stanley UK Group
 Morgan Stanley UK Group Financial ConglomeratesFinance Provides investment services | Finance |
Biotrin Holdings Ltd. | |
AccuNostics Ltd.
 AccuNostics Ltd. Miscellaneous Commercial ServicesCommercial Services Provides innovative scientific business development consultants | Commercial Services |
Neuravi Ltd.
 Neuravi Ltd. Medical SpecialtiesHealth Technology Designs and develops medical devices | Health Technology |
Eumom Marketing Ltd. | |
Travale Ltd. | |
Travale Marketing Ltd. | |
Optigen Patents Ltd.
 Optigen Patents Ltd. Miscellaneous Commercial ServicesCommercial Services Provides legal services | Commercial Services |
Delta Nominees Def Iii Ltd.
 Delta Nominees Def Iii Ltd. Regional BanksFinance Acts as a nominee/trust/depository | Finance |
Lightship Medical Ltd. | |
Indi Molecular, Inc.
 Indi Molecular, Inc. BiotechnologyHealth Technology Develops a synthetic class of diagnostic and therapeutic agents | Health Technology |
Merck Ventures BV
 Merck Ventures BV Investment ManagersFinance Merck Ventures invests in companies located in the Netherlands. The firm targets companies operating in the fields of healthcare, healthcare drug development, life science tools, electronics and frontier technology & sustainability sectors. It provides financing for early stage capital requirements. | Finance |
Axial Medical Printing Ltd.
 Axial Medical Printing Ltd. Commercial Printing/FormsCommercial Services Operates a medical technology firm which specializes in 3D printing within the healthcare sector | Commercial Services |
DNA Script SAS
 DNA Script SAS Miscellaneous Commercial ServicesCommercial Services Engages in R&D, produce single-stranded DNA sequence nucleotide chemistries and microbiology consumables | Commercial Services |
Eumedia Ltd.
 Eumedia Ltd. Internet Software/ServicesTechnology Services Operates as a digital pregnancy and parenting community | Technology Services |
Eumom Ltd.
 Eumom Ltd. Internet Software/ServicesTechnology Services Operates pregnancy, baby and parenting online platform | Technology Services |
Loki Steer Ltd.
 Loki Steer Ltd. Life/Health InsuranceFinance Provides life insurance services | Finance |
Rathmichael Residents Association Ltd. | |
Genesis Automation Ltd.
Genesis Automation Ltd. Packaged SoftwareTechnology Services Develops enterprise resource planning based technology modules for hospitals | Technology Services |
Plexium, Inc.
 Plexium, Inc. BiotechnologyHealth Technology Develops drug discovery and targeted protein degradation therapeutics technology platform | Health Technology |
Claret Capital Partners Ltd.
 Claret Capital Partners Ltd. Investment ManagersFinance Claret Capital Partners invests in middle market companies located in Europe. The firm focuses on health and technology sectors such as enterprise software & services, fintech & payroll, consumer & marketplaces, networks & industrial tech, marketing & adtech and healthcare. It It provides debt and equity financing for growth and buyout capital requirements with an investment size ranging from EUR 2 to 100 million. | Finance |
